These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2525318)

  • 21. [Peripheral vasodilators and beta-stimulants in the treatment of the initial stages of chronic circulatory insufficiency].
    Shevchenko VA
    Vrach Delo; 1987 Sep; (9):15-8. PubMed ID: 3424762
    [No Abstract]   [Full Text] [Related]  

  • 22. Glyceryl trinitrate.
    Nurs Times; 2006 Jan 24-30; 102(4):31. PubMed ID: 16459971
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacology of nicorandil in patients with congestive heart failure.
    Tice FD; Jungbluth GL; Binkley PF; MacKichan JJ; Mohrland JS; Wolf DL; Leier CV
    Clin Pharmacol Ther; 1992 Nov; 52(5):496-503. PubMed ID: 1424424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vasodilator therapy in cardiology].
    Cárdenas Loaeza M
    Cardiology; 1980; 66 Suppl 2():1-6. PubMed ID: 6116540
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of nicorandil on coronary spasm.
    Aizawa T; Ogasawara K; Nakamura F; Hirosaka A; Sakuma T; Nagashima K; Kato K
    Am J Cardiol; 1989 Jun; 63(21):75J-79J. PubMed ID: 2525331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylactic effect of nicorandil on perioperative coronary spasm].
    Hirose Y; Gamo M; Hirose M; Harigae M; Fujiwara C
    Masui; 1998 Jun; 47(6):734-7. PubMed ID: 9691595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of action of various ATP-sensitive potassium channel openers.
    Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):177-9. PubMed ID: 8849605
    [No Abstract]   [Full Text] [Related]  

  • 28. Nicorandil: the drug that keeps on giving.
    Barbato JC
    Hypertension; 2005 Oct; 46(4):647-8. PubMed ID: 16172416
    [No Abstract]   [Full Text] [Related]  

  • 29. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 30. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 31. Vagal tuning. A new concept in the treatment of supraventricular arrhythmias, angina pectoris, and heart failure.
    Bilgutay AM; Bilgutay IM; Merkel FK; Lillehei CW
    J Thorac Cardiovasc Surg; 1968 Jul; 56(1):71-82. PubMed ID: 5663136
    [No Abstract]   [Full Text] [Related]  

  • 32. A symposium: Congestive heart failure--advances in treatment. October 18, 1987, San Francisco, California. Proceedings.
    Am J Cardiol; 1989 Feb; 63(8):1D-37D. PubMed ID: 2537559
    [No Abstract]   [Full Text] [Related]  

  • 33. Nicorandil induced perianal ulceration.
    Tiernan JP; Baraza W; Chelham W; Garner J; Angel C; Shrestha BM
    JNMA J Nepal Med Assoc; 2009; 48(175):239-41. PubMed ID: 20795465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicorandil associated anal ulceration.
    Watson A; Suttie S; Fraser A; O'Kelly T; Loudon M
    Colorectal Dis; 2004 Sep; 6(5):330-1. PubMed ID: 15335365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
    Simpson D; Wellington K
    Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perianal ulceration and other cutaneous ulcerations complicating nicorandil therapy.
    Williams C; Tamuno P; Smith AJ; Walker SL; Lyon CC
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S116-7. PubMed ID: 17434035
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. Other angina pectoris agents].
    Lumholtz IB
    Sygeplejersken; 1980 May; 80(20):23. PubMed ID: 6902553
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
    IONA Study Group
    Am Heart J; 2005 Oct; 150(4):689. PubMed ID: 16209965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness of digoxin and sidnofarm in the initial stages of chronic circulatory failure].
    Bondarenko IP; Tkachev VA
    Vrach Delo; 1989 Oct; (10):73-5. PubMed ID: 2617991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991.
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-108. PubMed ID: 1282167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.